202 related articles for article (PubMed ID: 26098410)
1. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
Chen HL; Hsiao FY
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):841-8. PubMed ID: 26098410
[TBL] [Abstract][Full Text] [Related]
2. The association between domperidone and ventricular arrhythmia in the postpartum period.
Smolina K; Mintzes B; Hanley GE; Oberlander TF; Morgan SG
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1210-1214. PubMed ID: 27296864
[TBL] [Abstract][Full Text] [Related]
3. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
Johannes CB; Varas-Lorenzo C; McQuay LJ; Midkiff KD; Fife D
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):881-8. PubMed ID: 20652862
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
[TBL] [Abstract][Full Text] [Related]
5. Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China.
Zhang Y; Shu M; Liang W; Jiang K; Zhang D; Qiu H; Wu K
Adv Ther; 2020 Apr; 37(4):1564-1578. PubMed ID: 32146705
[TBL] [Abstract][Full Text] [Related]
6. Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.
Rojas-Fernandez C; Stephenson AL; Fischer HD; Wang X; Mestre T; Hutson JR; Pondal M; Lee DS; Rochon PA; Marras C
Drugs Aging; 2014 Nov; 31(11):805-13. PubMed ID: 25227452
[TBL] [Abstract][Full Text] [Related]
7. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
[TBL] [Abstract][Full Text] [Related]
8. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
Leelakanok N; Holcombe A; Schweizer ML
Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
[TBL] [Abstract][Full Text] [Related]
9. Effect of domperidone on QT interval in neonates.
Djeddi D; Kongolo G; Lefaix C; Mounard J; Léké A
J Pediatr; 2008 Nov; 153(5):663-6. PubMed ID: 18589449
[TBL] [Abstract][Full Text] [Related]
10. Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis.
Mehrabadi A; Reynier P; Platt RW; Filion KB
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1316-1324. PubMed ID: 30106193
[TBL] [Abstract][Full Text] [Related]
11. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
Ou LB; Moriello C; Douros A; Filion KB
Br J Clin Pharmacol; 2021 Oct; 87(10):3649-3658. PubMed ID: 33439512
[TBL] [Abstract][Full Text] [Related]
12. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study.
Wu CS; Tsai YT; Tsai HJ
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713294
[TBL] [Abstract][Full Text] [Related]
14. Domperidone: ventricular arrhythmia and sudden death (continued).
Prescrire Int; 2012 Jul; 21(129):183. PubMed ID: 22852288
[TBL] [Abstract][Full Text] [Related]
15. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients.
Wang PS; Levin R; Zhao SZ; Avorn J
J Am Geriatr Soc; 2002 Jan; 50(1):117-24. PubMed ID: 12028256
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UK.
Simeonova M; de Vries F; Pouwels S; Driessen JHM; Leufkens HGM; Cadarette SM; Burden AM
Br J Clin Pharmacol; 2018 Nov; 84(11):2551-2561. PubMed ID: 29975795
[TBL] [Abstract][Full Text] [Related]
17. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
[TBL] [Abstract][Full Text] [Related]
19. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
Buffery PJ; Strother RM
N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
[TBL] [Abstract][Full Text] [Related]
20. Risk of domperidone induced severe ventricular arrhythmia.
Song BG; Lee YC; Min YW; Kim K; Lee H; Son HJ; Rhee PL
Sci Rep; 2020 Jul; 10(1):12158. PubMed ID: 32699312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
